Related Experiment Videos
Transcription factors.
1Garvan Institute of Medical Research & University of New South Wales, 384 Victoria Street, Darlinghurst, NSW, 2010, Australia.
Best Practice & Research. Clinical Rheumatology
|January 29, 2002
Summary
Transcription factors regulate gene expression and cell phenotype. Targeting specific transcription factors, like NF-kappaB, may offer safer and more effective treatments for rheumatic diseases.
Area of Science:
- Molecular Biology
- Immunology
- Rheumatology
Background:
- Gene expression regulation by transcription factors is crucial for cell phenotype.
- Inflammatory processes involve induced gene expression, contributing to rheumatic diseases.
- Key transcription factors like NF-kappaB, AP-1, NFATs, and STATs drive inflammatory gene expression.
Purpose of the Study:
- To review the role of transcription factors in rheumatic disease pathogenesis.
- To discuss current therapeutic strategies targeting transcription factors.
- To explore the potential of novel transcription factor-specific drugs.
Main Methods:
- Literature review of transcription factor function in inflammation and rheumatic diseases.
- Analysis of existing anti-rheumatic and anti-inflammatory drug mechanisms.
- Discussion of future therapeutic development targeting transcription factors.
Main Results:
- Specific transcription factors (NF-kappaB, AP-1, NFATs, STATs) are central to inflammatory gene expression in rheumatic diseases.
- Current drugs can modify these transcription factors, but efficacy and side effects are limitations.
- Targeting transcription factors, particularly NF-kappaB, shows therapeutic promise.
Conclusions:
- Transcription factors are critical mediators in the pathogenesis of rheumatic diseases.
- Developing drugs that specifically target transcription factors could improve treatment safety and efficacy.
- NF-kappaB is a key target for future anti-rheumatic drug development.